Purchase Order HHSN272201301080P

This is a $2,054,175.16 federal contract awarded by the Centers for Disease Control and Prevention (CDC) to PPD Development LP, a global contract research organization (CRO), for monitoring services in support of the Tuberculosis Trials Consortium (TBTC). The contract is a 5-year definitive contract with a time and materials pricing type. It will involve on-site monitoring, quality assurance, investigational product management, and reporting for TBTC clinical trials of new drugs, diagnostics,...

This is a $13,523,501.30 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to The Research Institute Of The Mcgill University Health Centre for Tuberculosis Trials Consortium Services. The contract has a period of performance through December 31, 2030 and was awarded on January 1, 2021. It is a cost-no-fee contract to support clinical trials and research on the treatment, diagnosis, and prevention of tuberculosis, including studies of latent TB infection in...

The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. government, awarded a $13,505.01 firm fixed-price purchase order contract to University Research Co., LLC to provide support services to conduct studies on malaria in Cambodia. The contract, which has no set-aside designation, is titled "AMBIS #1776938 SUPPORT SERVICES TO CONDUCT STUDIES ON MALARIA IN CAMBODIA (COW BAITED TENT STUDY)" and has an ultimate completion date of September 15,...

This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to the International Tuberculosis Research Center (ITRC) on August 14, 2014 for the "LTBI STUDY (2ND YEAR)" project. The contract has a ceiling value of $150,000.00 and a completion date of August 14, 2014. The contract is not designated as a set-aside. Based on the project title, this contract appears to be part of NIAID's larger efforts related to the...

This is a purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to the National Institute For Research In Tuberculosis, a non-profit organization that operates as a hospital. The $537,500.00 firm fixed price award is to provide support to conduct studies on tuberculosis in India. The contract has a performance period ending on May 31, 2019 and was awarded on November 30, 2015. No set-aside was used for this contract. The National...

This is a definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Siris Pharmaceutical Services LLC, a woman-owned small business, to provide tuberculosis (TB) clinical trials management support. The contract has a ceiling value of $2,395,614.70 and is a time and materials contract with a period of performance ending on September 10, 2026. The contract is designated as a total small business set-aside. This contract supports the CDC's efforts to advance TB research...

This is a definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Case Western Reserve University's Office of Research Administration Division, doing business as University Hospitals of Cleveland, with a ceiling value of $15,729,937.34. The contract is for tuberculosis trials and consortium services over a 10-year period of performance from January 1, 2021 to December 31, 2030. There is no set-aside designation for this award. The contract requires the vendor to...

The National Institute of Child Health and Human Development awarded a $299,389 cost plus fixed fee delivery order contract to Westat, Inc. to conduct a Phase I study of the pharmacokinetics, safety and acceptability of a single dose of pretomanid added to an optimized background regimen in children with rifampicin resistant tuberculosis as part of the IMPAACT 2034 major program. The place of performance for the research is Potomac, Maryland and work is expected to be completed by December...

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order contract to University Research Co., LLC (URC) for the AMBIS 1865527 Malaria Research Initiative to Secure Data and Obtain an Estimated 100 DNA Samples in Banteay Meanchey Province, Cambodia. The contract has a potential value of $237,102.00 and a completion date of March 25, 2019. URC is a for-profit limited liability company...

This is a cost-plus-fixed-fee contract awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to Sri International, a non-profit research institute. The $1,439,619 contract supports pharmacology and toxicology studies of several experimental compounds, including amikacin, TLC-ART-101, NDB-compounds, and sutezolid. The goal is to develop mitochondrial toxicity assays to support the preclinical development of AIDS therapeutics under the NIAID's...